Home › Funds › Cormorant Asset Management, LP › DNTH

Cormorant Asset Management, LP position in DNTH

DIANTHUS THERAPEUTICS INC COM · Health Care

Cormorant Asset Management, LP reported holding 750,000 shares of DNTH (DIANTHUS THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$73.1M, representing 3.75% of its reported portfolio and ranking #10 among its reported holdings. Cormorant Asset Management, LP has disclosed DNTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)750.00K sh
Reported value held$73.11M
Portfolio Weight3.75%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's DNTH position evolved

Cormorant Asset Management, LP first disclosed a stake in DNTH in Q1 2026 at 950,000 shares (US$79.7M). Across 2 filings, Cormorant Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 750,000 shares valued at US$73.1M — a reduction of -200,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 950.00K $79.72M New
Q2 2026 750.00K $73.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC COM) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has Cormorant Asset Management, LP held DNTH?

Cormorant Asset Management, LP has disclosed DNTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Cormorant Asset Management, LP's current position in DNTH?

As of Q2 2026, Cormorant Asset Management, LP holds 750.00K shares of DNTH (DIANTHUS THERAPEUTICS INC COM), valued at $73.11M, representing 3.75% of its reported portfolio and ranking #10.

Has Cormorant Asset Management, LP been buying or selling DNTH?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in DNTH.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.